Concord Biotech has announced the successful completion of NAFDAC inspection (National Agency for Food and Drug Administration) at our Oral Solid Dosage (OSD) Unit-2, facility located at Valthera, Gujarat. The inspection was conducted from October 06’ 2025 to October 07’ 2025. This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of our operations. It reflects its dedication to excellence and its continued focus on meeting the rigorous requirements of global regulatory authorities.
The above information is a part of company’s filings submitted to BSE.
